Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
12.06
+0.01 (0.08%)
Nov 13, 2026, 4:00 PM EST

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 137.69M CAD in the quarter ending September 30, 2026, with 13.28% growth. This brings the company's total for the last twelve months to 563.45M, up 36.15% year-over-year. In the year 2025, Knight Therapeutics had annual revenue of 450.09M with 21.22% growth. That makes Knight Therapeutics the 12,705th largest company in the world by revenue and 283rd in Canada.

Revenue (ttm)
563.45M
Revenue Growth
+36.15%
P/S Ratio
2.10
Revenue / Employee
678.85K
Employees
830
Market Cap
1.19B

Revenue Chart

Revenue by Geography

  • Brazil 182.52M 40.6%
  • Canada 84.28M 18.7%
  • Colombia 55.00M 12.2%
  • Rest of The Latin America 43.02M 9.6%
  • Argentina 40.75M 9.1%
  • Mexico 24.50M 5.4%
  • Other 20.02M 4.4%
Fiscal year ended Dec 31, 2025 See the full Knight Therapeutics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025450.09M78.78M21.22%
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 201947.46M34.96M279.69%
Dec 31, 201812.50M3.87M44.78%
Dec 31, 20178.63M2.69M45.35%
Dec 31, 20165.94M4.90M472.81%
Dec 31, 20151.04M672.00K184.11%
Dec 31, 2014365.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.